1/27/2023  5:31:24 PM Chg. +0.250 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
13.500CHF +1.89% 1,809
Turnover: 24,399.950
13.250Bid Size: 500 15.000Ask Size: 50 145.16 mill.CHF - -

Business description

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, Indien and the United States in one business segment, Telemedicine services. SHL was founded in 1987 by Yoram Alroy and Elon Shalev.
 

Management board & Supervisory board

CEO
Erez Nachtomy
Management board
Linus Drop, Yoni Dagan, Yossi Vadnagra
Supervisory board
Yariv Alroy, David Salton, Devorah Kimhi, Dr. Amir Lerman, Erez Alroy, Erez Nachtomy, Yehoshua Abramovich
 

Company data

Name: SHL TeleMedicine Ltd.
Address: 90 Yigal Alon St.,IL-67891 Tel Aviv
Phone: +972-3-5612212
Fax: +972-3-6242414
E-mail: -
Internet: www.shl-telemedicine.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 29.43%
IPO date: -

Investor relations

Name: Martin Meier-Pfister
IR phone: +41-43-2448140
IR Fax: -
IR e-mail: martin.meier-pfister@irfcom.ch

Company calendar

CW 16 | 4/20/2023 4th Quarter/Annual Report
 

Main Shareholders

Cai Mengke and Shen Kun
 
41.27%
Freefloat
 
29.43%
Alroy Group
 
17.33%
More Provident Funds
 
6.18%
Value Base Group
 
5.79%